Yonghe Medical Group Co., Ltd. commences an Equity Buyback for 52,708,041 shares, representing 10% of its issued share capital, under the authorization approved on June 16, 2023.

Yonghe Medical Group Co., Ltd. (SEHK:2279) commences share repurchases on January 18, 2024, under the program mandated by the shareholders in the Annual General Meeting held on June 16, 2023. As per the mandate, the company is authorized to repurchase up to 52,708,041 shares, representing 10% of its issued share capital. The repurchases will result in an increase in the net asset value and/or earnings per share.

The repurchase program will be funded out of funds legally available for the purpose in accordance with the Articles of Association, the Companies Act and/or any other applicable laws and regulations in the Cayman Islands. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As at June 16, 2023, the company has 527,080,416 shares in issue.